Initial values of alpha 1 antitrypsin and transferrin in patients with pulmonary tuberculosis

M. Trajcevska, A. Sandevski, L. Simonovska (Skopje, Fyrom)

Source: Annual Congress 2007 - Difficult tuberculosis cases II
Session: Difficult tuberculosis cases II
Session type: Thematic Poster Session
Number: 3843
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Trajcevska, A. Sandevski, L. Simonovska (Skopje, Fyrom). Initial values of alpha 1 antitrypsin and transferrin in patients with pulmonary tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 3843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019


Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003

Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Association between alpha 1 antitrypsin and bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015

Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007


Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021

Effect of serum alpha-1-antitrypsin (AAT) and alpha-2-macroglobulin (AMG) levels on sputum conversion in active pulmonary tuberculosis
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008


Plasma stromal derived factor 1 alpha levels in pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 141s
Year: 2006

The prognostic value of CT-based lung density histograms in patients with severe alpha-1 antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 296s
Year: 2004

Prognostic value of C-reactive protein and alpha 1 acid glycoprotein in pulmonary tuberculosis
Source: Annual Congress 2003 - Epidemiology of tuberculosis in adults and children
Year: 2003


Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil
Source: Eur Respir J 2003; 22: Suppl. 45, 499s
Year: 2003

Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010



The results of alpha-1 antitrypsine (AAT) phenotyping in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 260s
Year: 2002

Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019

Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011